CSU > Cardiovascular Research Group
Cardiovascular disease is a leading cause of morbidity and mortality in Australia and around the world. The prevalence of heart, stroke and vascular disease in Australia has increased by more than 18% over the last decades. Over 90% of Australian adults have one or more modifiable risk factors for cardiovascular disease. Development of new strategies in the prevention and treatment of cardiovascular disease is a national research priority.
The cardiovascular research group is a university-designated multidisciplinary research unit. It is one of the four major research groups in the Centre for Inland Health, a university strategic research centre. The cardiovascular research group is comprised of academic staff members from several Schools at Charles Sturt University (CSU), and a number of specialist physicians from eight Australian and overseas hospitals. The members of this group are currently working collaboratively on a range of research projects, from diagnosis to novel therapies for cardiovascular and respiratory diseases.
Members of the group have adopted a trans-disciplinary approach to conceptualise, design and conduct high quality research projects. Within the group there is a wide range of expertise in cardiovascular medicine, clinical pharmacology, and nuclear medicine, and medical science. The extensive research and clinical skills enable the group to investigate major cardiovascular and respiratory diseases from biomedical and clinical perspectives.
Head of Research Group
Prof Lexin Wang, MD, PhD
Professor of Clinical Pharmacology
School of Biomedical Sciences
Faculty of Science
Charles Sturt University
Telephone: 61 02 69332905
Email: lwang@csu.edu.au
Deputy Head of Research Group
Dr Geoff Currie, MMedRadSc, MAppMngt, MBA, PhD, ANMT,
CNMT
Senior Lecturer in Nuclear Medicine
School of Dentisty & Health Sciences
Faculty of Science
Charles Sturt University
Telephone: 61 02 69332822
Email: gcurrie@csu.edu.au